1-2 of 2
Ichiei Narita
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease Database

Hajime Nagasu, Yuichiro Yano, Hiroshi Kanegae, Hiddo J.L. Heerspink, Masaomi Nangaku, Yosuke Hirakawa, Yuka Sugawara, Naoki Nakagawa, Yuji Tani, Jun Wada, Hitoshi Sugiyama, Kazuhiko Tsuruya, Toshiaki Nakano, Shoichi Maruyama, Takashi Wada, Kunihiro Yamagata, Ichiei Narita, Kouichi Tamura, Motoko Yanagita, Yoshio Terada, Takashi Shigematsu, Tadashi Sofue, Takafumi Ito, Hirokazu Okada, Naoki Nakashima, Hiromi Kataoka, Kazuhiko Ohe, Mihoko Okada, Seiji Itano, Akira Nishiyama, Eiichiro Kanda, Kohjiro Ueki, Naoki Kashihara
Journal: Diabetes Care
Diabetes Care 2021;44(11):2542–2551
https://doi.org/10.2337/dc21-1081
Published: 18 October 2021
View article titled, Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease Database
Open the PDF for Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease Database in another window
Journal Articles

Significance of Urinary Full-Length and Ectodomain Forms of Megalin in Patients With Type 2 Diabetes

Shinya Ogasawara, Michihiro Hosojima, MD, Ryohei Kaseda, MD, Hideyuki Kabasawa, MD, Keiko Yamamoto-Kabasawa, MD, Hiroyuki Kurosawa, Hiroyoshi Sato, PHD, Noriaki Iino, MD, Tetsuro Takeda, MD, Yoshiki Suzuki, MD, Ichiei Narita, MD, Kunihiro Yamagata, MD, Yasuhiko Tomino, MD, Fumitake Gejyo, MD, Yoshiaki Hirayama, Sakari Sekine, PHD, Akihiko Saito, MD
Journal: Diabetes Care
Diabetes Care 2012;35(5):1112–1118
https://doi.org/10.2337/dc11-1684
Published: 11 April 2012
View article titled, Significance of Urinary Full-Length and Ectodomain Forms of Megalin in Patients With Type 2 Diabetes
Open the PDF for Significance of Urinary Full-Length and Ectodomain Forms of Megalin in Patients With Type 2 Diabetes in another window
Includes: Supplementary data